Q2 EPS Estimate for Corbus Pharmaceuticals Cut by Analyst
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Equities researchers at HC Wainwright cut their Q2 2025 earnings estimates for Corbus Pharmaceuticals in a report released on Wednesday, May 7th. HC Wainwright analyst A. Maldonado now expects that the biopharmaceutical company will earn ($1.54) per share for the quarter, down from their previous forecast […]
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP – Free Report) – Equities researchers at HC Wainwright cut their Q2 2025 earnings estimates for Corbus Pharmaceuticals in a report released on Wednesday, May 7th. HC Wainwright analyst A. Maldonado now expects that the biopharmaceutical company will earn ($1.54) per share for the quarter, down from their previous forecast […]
